GlassScriptPhysician profile
Celso F Palmieri
NPI 1104095520
$4,766.74
in general payments reported to CMS, 2019-2025
11 companies · $845 in 2025
The $845 reported for 2025 was more than what 80% of Oral & Maxillofacial Surgery providers received nationally (typical 2025 total: $184).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $126 · 2020: $20.54 · 2021: $665 · 2022: $850 · 2023: $1,313 · 2024: $947 · 2025: $845.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,105.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,104.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $2,159.24 | 2021-2025 | Trumatch, Matrixorthognathic, Na |
| Kls-Martin L.P. | $1,128.98 | 2019-2025 | |
| Axogen | $470.07 | 2020-2025 | Avance Nerve Graft, Axoguard Ha+ Nerve Protector, Axoguard Nerve Cap |
| Zimvie INC. | $273.59 | 2022-2024 | |
| Straumann USA LLC | $236.80 | 2022 | |
| Stryker Corporation | $191.21 | 2021-2024 | Na |
| Nobel Biocare USA | $110.01 | 2021-2023 | Nobelactive |
| Sanara Medtech INC. | $106.79 | 2022 | |
| Biogen, INC. | $52.07 | 2022-2024 | Spinraza |
| Medtronic, INC. | $20.79 | 2022 | |
| Sarepta Therapeutics, INC. | $17.19 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Celso Palmieri listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.